Replies to post #30745 on RespireRx Pharmaceuticals Inc (fka RSPI)

[haysaw]

There is no higher authority than you, sire. :)

I guess we hit the end of the road...

[Aiming4]

Neuro - your explanations have been perfectly clear and answered all of the relevant questions pretty conclusively in this mini-discussion about the AD trial.

There are things I have some reservations about and questions over in terms of mgmt decisions, but not this one.

Had Cortex thought this was a valid avenue to pursue, factoring in all variables at each checkpoint when such a decision could have been made, clearly they would have done so.

[gfp927z]

Neuro, I was wondering if you thought Biovail might possibly have some interest in Cortex / Ampakines? I saw your comments on the NI website, and that Chris Fibiger from Amgen is now Biovail's Chief Science Officer.

If I remember correctly, Fibiger made some positive comments a number of years ago about AMPA upmodulation when he was at Amgen (I remember his name from that period, although I no longer have those notes). With Biovail moving into CNS, and the Fibiger connection, any possibility of interest from Biovail?

Thanks.



From your NI website -

>>> On a smaller but more nimble scale, Biovail has quietly buttressed its move into CNS with an impressive external advisor roster, in the wake of hiring Amgen alumnus Chris Fibiger as CSO. They have the size, acumen, and resources required to take full advantage of the current environment, although they also have a significant shareholder/former CEO bent on impeding their move into CNS. <<<